Literature DB >> 11606458

PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway.

G K Chan1, R A Deckelbaum, I Bolivar, D Goltzman, A C Karaplis.   

Abstract

We examined the capacity of PTHrP to modulate the terminal differentiation of the preadipocytic cell line, 3T3-L1. These cells express endogenous PTHrP and its receptor, but expression levels were undetectable after differentiation into mature adipocytes. Cells stably overexpressing PTHrP failed to differentiate when induced to undergo adipogenesis and proliferated at a faster rate. MAPK activity was elevated in PTHrP-transfected 3T3-L1 cells, and treatment with the PKA inhibitor H-8 decreased this activity. Inhibition of MAPK kinase with PD098059 permitted terminal differentiation of PTHrP-transfected 3T3-L1 cells to proceed. Although PPAR gamma gene expression levels remained relatively constant in the PTHrP-transfected cells, PPAR gamma phosphorylation was enhanced. Furthermore, the capacity of PPAR gamma to stimulate transcription in the presence of troglitazone was diminished by PTHrP. Expression of the PPAR gamma-regulated adipocyte specific gene aP2 transiently rose and then fell in PTHrP-transfected cells. These results indicate that PTHrP can increase MAPK activity in 3T3-L1 cells via the PKA pathway, thereby enhancing PPAR gamma phosphorylation. This modification can inactivate the transcriptional enhancing activity of PPAR gamma and diminish the expression of adipocyte-specific genes. These studies therefore demonstrate that PTHrP may inhibit the terminal differentiation of preadipocytes and describe a molecular pathway by which this action can be achieved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606458     DOI: 10.1210/endo.142.11.8515

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  23 in total

1.  Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology.

Authors:  Siddharth Sukumaran; Bai Xue; William J Jusko; Debra C Dubois; Richard R Almon
Journal:  Physiol Genomics       Date:  2010-08-03       Impact factor: 3.107

2.  Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway.

Authors:  Z C Dang; C W G M Lowik
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

Review 3.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

Review 4.  Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication.

Authors:  Meilian Liu; Feng Liu
Journal:  Biochimie       Date:  2012-02-10       Impact factor: 4.079

5.  Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.

Authors:  Dengshun Miao; Bin He; Yebin Jiang; Tatsuya Kobayashi; Maria A Sorocéanu; Jenny Zhao; Hanyi Su; Xinkang Tong; Norio Amizuka; Ajay Gupta; Harry K Genant; Henry M Kronenberg; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

6.  Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate.

Authors:  Yi Fan; Jun-Ichi Hanai; Phuong T Le; Ruiye Bi; David Maridas; Victoria DeMambro; Carolina A Figueroa; Serkan Kir; Xuedong Zhou; Michael Mannstadt; Roland Baron; Roderick T Bronson; Mark C Horowitz; Joy Y Wu; John P Bilezikian; David W Dempster; Clifford J Rosen; Beate Lanske
Journal:  Cell Metab       Date:  2017-02-02       Impact factor: 27.287

7.  The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling.

Authors:  Baowen Du; William P Cawthorn; Alison Su; Casey R Doucette; Yao Yao; Nahid Hemati; Sarah Kampert; Colin McCoin; David T Broome; Clifford J Rosen; Gongshe Yang; Ormond A MacDougald
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

8.  Loss of Gsα early in the osteoblast lineage favors adipogenic differentiation of mesenchymal progenitors and committed osteoblast precursors.

Authors:  Partha Sinha; Piia Aarnisalo; Rhiannon Chubb; Noriaki Ono; Keertik Fulzele; Martin Selig; Hamid Saeed; Min Chen; Lee S Weinstein; Paola Divieti Pajevic; Henry M Kronenberg; Joy Y Wu
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

9.  The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.

Authors:  Antonio Casado-Diaz; Raquel Santiago-Mora; José Manuel Quesada
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

Review 10.  The TIP39-PTH2 receptor system: unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms.

Authors:  Arpád Dobolyi; Miklós Palkovits; Ted B Usdin
Journal:  Prog Neurobiol       Date:  2009-10-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.